Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Gossamer Bio (GOSS) Interest Expenses (2022 - 2025)

Historic Interest Expenses for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $2.7 million.

  • Gossamer Bio's Interest Expenses rose 51.21% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year decrease of 867.03%. This contributed to the annual value of $11.5 million for FY2024, which is 1475.83% down from last year.
  • Per Gossamer Bio's latest filing, its Interest Expenses stood at $2.7 million for Q3 2025, which was up 51.21% from $2.7 million recorded in Q2 2025.
  • Over the past 5 years, Gossamer Bio's Interest Expenses peaked at $3.5 million during Q1 2023, and registered a low of $2.7 million during Q3 2024.
  • For the 4-year period, Gossamer Bio's Interest Expenses averaged around $3.1 million, with its median value being $3.2 million (2023).
  • In the last 5 years, Gossamer Bio's Interest Expenses skyrocketed by 95.18% in 2023 and then tumbled by 1821.72% in 2024.
  • Over the past 4 years, Gossamer Bio's Interest Expenses (Quarter) stood at $3.5 million in 2022, then fell by 6.31% to $3.2 million in 2023, then decreased by 15.47% to $2.7 million in 2024, then grew by 0.37% to $2.7 million in 2025.
  • Its Interest Expenses stands at $2.7 million for Q3 2025, versus $2.7 million for Q2 2025 and $2.7 million for Q1 2025.